Solingen, Germany

Ute Krüger

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Qiagen Gmbh. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ute Krüger. Retrieved from https://idiyas.com/inventor/ute-krüger-akg871yt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ute Krüger: Innovator in Cell Transformation Technology

Introduction

Ute Krüger is a prominent inventor based in Solingen, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of cell transformation. Her innovative methods have the potential to advance therapeutic treatments and gene therapy.

Latest Patents

Ute Krüger holds a patent for a method of production of a transformed cell. This method involves incorporating a biomolecule into a cell through a complex formed by a biomolecule and a polymer. The process includes the production of this complex and the subsequent incorporation of the biomolecule into the cell. The patent also covers the transformed cell obtained by this method, the use of a specific polymer for biomolecule incorporation, and various therapeutic applications.

Career Highlights

Ute Krüger is associated with Qiagen GmbH, a leading company in the field of molecular biology. Her work at Qiagen has allowed her to focus on innovative solutions that enhance the capabilities of gene therapy and biomolecular research.

Collaborations

Ute collaborates with Christoph Erbacher, contributing to advancements in their shared field of expertise. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Ute Krüger's contributions to biotechnology, particularly in cell transformation methods, highlight her role as a key innovator in the industry. Her work continues to pave the way for advancements in therapeutic treatments and gene therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…